Mallinckrodt PLC (MNK)
1.90
-0.55
(-22.45%)
USD |
NYAM |
Jun 05, 10:14
Mallinckrodt Enterprise Value: 2.638B for June 2, 2023
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 02, 2023 | 2.638B |
| June 01, 2023 | 2.640B |
| May 31, 2023 | 2.642B |
| May 30, 2023 | 2.644B |
| May 26, 2023 | 2.645B |
| May 25, 2023 | 2.644B |
| May 24, 2023 | 2.647B |
| May 23, 2023 | 2.652B |
| May 22, 2023 | 2.650B |
| May 19, 2023 | 2.689B |
| May 18, 2023 | 2.621B |
| May 17, 2023 | 2.627B |
| May 16, 2023 | 2.631B |
| May 15, 2023 | 2.642B |
| May 12, 2023 | 2.642B |
| May 11, 2023 | 2.647B |
| May 10, 2023 | 2.657B |
| May 09, 2023 | 2.659B |
| May 08, 2023 | 2.678B |
| May 05, 2023 | 2.673B |
| May 04, 2023 | 2.677B |
| May 03, 2023 | 2.678B |
| May 02, 2023 | 2.676B |
| May 01, 2023 | 2.678B |
| April 28, 2023 | 2.683B |
| Date | Value |
|---|---|
| April 27, 2023 | 2.676B |
| April 26, 2023 | 2.681B |
| April 25, 2023 | 2.681B |
| April 24, 2023 | 2.684B |
| April 21, 2023 | 2.685B |
| April 20, 2023 | 2.682B |
| April 19, 2023 | 2.685B |
| April 18, 2023 | 2.684B |
| April 17, 2023 | 2.676B |
| April 14, 2023 | 2.678B |
| April 13, 2023 | 2.670B |
| April 12, 2023 | 2.675B |
| April 11, 2023 | 2.675B |
| April 10, 2023 | 2.667B |
| April 06, 2023 | 2.679B |
| April 05, 2023 | 2.684B |
| April 04, 2023 | 2.697B |
| April 03, 2023 | 2.704B |
| March 31, 2023 | 2.702B |
| March 30, 2023 | 2.784B |
| March 29, 2023 | 2.787B |
| March 28, 2023 | 2.790B |
| March 27, 2023 | 2.793B |
| March 24, 2023 | 2.793B |
| March 23, 2023 | 2.791B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.593B
Minimum
Jun 17 2022
4.820B
Maximum
Jun 30 2022
2.805B
Average
2.809B
Median
Dec 19 2022
Enterprise Value Benchmarks
| Perrigo Co PLC | 8.013B |
| Alkermes PLC | 4.594B |
| Jazz Pharmaceuticals PLC | 12.77B |
| Horizon Therapeutics PLC | 23.07B |
| Iterum Therapeutics PLC | -6.028M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -249.30M |
| Revenue (Quarterly) | 424.60M |
| Total Expenses (Quarterly) | 526.00M |
| EPS Diluted (Quarterly) | -18.93 |
| Gross Profit Margin (Quarterly) | 11.73% |
| Profit Margin (Quarterly) | -58.71% |
| Earnings Yield | -3.51K% |
| Normalized Earnings Yield | -3138.10 |